However, surprisingly, IL-2 could partially recover the degranulation function of CTL/NK cells in patients, according to the author, which may partially explain why patients with FHL-4 had a later onset age and longer remission periods without any specific treatment than that of patients with FHL-2 and FHL-3, but the mechanism is still unclear. This evidence concerns the gene IL2 and hemophagocytic syndrome.